Copyright
©The Author(s) 2023.
World J Obstet Gynecol. Dec 28, 2023; 12(4): 33-44
Published online Dec 28, 2023. doi: 10.5317/wjog.v12.i4.33
Published online Dec 28, 2023. doi: 10.5317/wjog.v12.i4.33
Name | Components | Trade name | Maximum dose and metabolism | Administration | Side effects | Contraindications and precautions |
Iron sucrose[30,51,76,77] | Polynuclear iron (III) hydroxide in sucrose. Dose of elemental iron = 20 mg/mL | Venofer® | Maximum dose for a single infusion is 300 mg. The infusion can be repeated up to 3 times per week. After administration, it reaches peak level at 10 min after infusion. Half-life is about 6-20 h | Test dose is required if drug allergies present, only for the first dose administration and only in new patients. Intravenous infusion should be given within at least 15 min | Anaphylaxis phlebitis; Pain and swelling in the infusion area; Constipation; Blurred vision; Headache; Pruritus and rash; Drowsiness; Metallic taste; Slow or fast heartbeat; Sweating; Tingling of the hands or feet; Unusual tiredness or weakness | First trimester of pregnancy; Hypersensitivity to iron sucrose; Anaemia not caused by iron deficiency; Iron overload; Known or genetic tendency to haemochromatosis; Lactation (insufficient data) |
Iron dextran[30,78] | Ferric hydroxide or ferric oxyhydroxide combined with partially hydrolysed low molecular-weight dextran; Dose of elemental iron = 50 mg/mL | INFeD® (IV or IM use); Cosmofer® (low molecular weight – both IV and IM routes of administration) | The intravenous dose is 100-200 mg (or 20 mg/kg), administered ≤ 3 times per week. Reticulocytosis may begin by 4th day after the intravenous infusion of the total dose. Peak level Reaches a maximum by about 10th day. Half-life is about 5-30 h | Test dose is required before every intravenous administration. Intravenous infusion should be given within 4-6 h. Intramuscular injection of 100 Cosmofer can be injected into alternate buttocks ≤ 3 times per week | Anaphylaxis; Arthralgia; Chills; Dizziness; Fever; Headache; Malaise; Myalgia; Metallic taste; Pain and swelling in the infusion area; Low blood pressure | Heart disease; Liver disease; Kidney disease; Rheumatoid arthritis; Bleeding or blood clotting disorder; Stomach bleeding; Asthma or allergies; Allergy; Using a beta-blocker medicine; Pregnancy |
Iron polymaltose[57,79] | Iron (III) –hydroxide (trivalent iron, Fe3+) with the carrier polymaltose | FerrumH®; Ferrosig® | Each 2 mL ampoule contains 318 mg iron polymaltose equivalent to 100 mg iron III (50 mg per mL). It is used for postnatal women when the required dose of iron is > 1000 mg. Average total dose of iron polymaltose infusion is usually between 1000-2500 mg for adults. Maximum dose for a single infusion is 2500 mg | Total dose is administered within 5 h; The first 50 mL should be administered slowly (5-10 drops/min); The intravenous preparation should not be mixed with any other medication | Anaphylaxis; Itching; Mild erythematous or urticarial rash; Lower quadrant abdominal pain; Dizziness; Chest and back pain; Occasional arrhythmias; Dyspnoea; Flushing; Sweating; Injection/infusion site pain | First trimester of pregnancy; Iron overload; Chronic polyarthritis; Acute renal infection; Uncontrolled hyperparathyroidism; Hepatic cirrhosis; Infectious hepatitis; Liver infection; Bronchial asthma; Anaemia not caused by iron deficiency (i.e. microcytic anaemia); Iron overload; Anaemia not caused by iron deficiency (i.e. microcytic anaemia); Iron overload; Lactation (no data available) |
Iron carboxymaltose[30,51,80] | Ferric carboxymaltose. Dose of elemental iron = 50 mg/mL. | Ferinject®; Ferrosig® | Each vial contains 50 mg/mL Ferric carboxymaltose and they come as 2 mL (100 mg) or 10 mL (500 mg) vials. Maximum dose for a single infusion for patients ≥ 35 kg is 1000 mg/wk, or a maximum of 15 mg/kg/wk can be administered. Administered IV dose is 1000 mg or up to 15 mg/kg/wk. Half-life is about 7-12 h | Test dose is not required before intravenous administration. It is administered within 30-45 min | Anaphylaxis (rare); Headache; Gastrointestinal symptoms; Nausea; Rash; Injection/infusion site reactions; Hypophosphataemia; Flushing; Dizziness; Hypertension | Anaemia not caused by iron deficiency (i.e. microcytic anaemia); Iron overload; Acute or chronic infection; Asthma; Eczema; Atopic allergies; Liver dysfunction; Children under 14 yr |
Iron isomaltoside[30] | Dose of elemental iron (ferric derisomaltose) = 100 mg/mL | Monofer® | Administered IV dose is 100-200 mg up to 3 times a week. Half-life is about 1-4 d | Test dose is not required before intravenous administration. Doses up to 10 mg/Kg should be administered within at least 30 min. Doses larger than 10 mg/kg should be administered within at least one hour | Anaphylaxis; Infusion site complications; Myalgia; Phlebitis; Headache; Tachycardia; Hypotension; Hypertension; Chest pain; Dyspnoea; Bronchospasm; Abdominal pain; Vomiting; Dyspepsia; Constipation; Diarrhoea; Hypophosphataemia | Hypersensitivity to ferric substances; Non-iron deficiency anaemia; Iron overload; Unavailability of resuscitation facility; Liver dysfunction; Chronic infection; Asthma; Eczema; Atopic allergies; Ongoing bacteraemia; First trimester of pregnancy; Lactation (no data available) |
Ferumoxytol[81] | Superparamagnetic iron oxide comound linked to polyglucose sorbitol carboxymethylether; Dose of elemental iron = 30 mg/mL | Feraheme® | Maximum dose for a single infusion is 510 mg | 510 mg Ferumoxytol is Administered over within 15-30 min. Second dose of 510 mg is administered approximately one week later | Anaphylaxis; Abdominal pain; Headache; Blurred vision; Confusion; Fever; Flush; Chest tightness; Back pain; Nausea; Nasal congestion; Itching; Scratchy throat and cough; Sweating; Hands or feet tingling | Hypersensitivity to ferric substances; Iron overload syndrome; Low blood pressure; Non-iron deficiency anaemia; Hypotension; MRI study; First trimester of pregnancy; Lactation (no data available) |
Iron gluconate[48] | Dose of elemental iron = 12.5 mg/mL with Benxyl alcohol as preservative | Ferrlecit® | Maximum dose for a single infusion is 125 mg. Half-life is 1 h | Test dose is required if drug allergies present | Allergic reaction; Rash; Itching; Swelling; Severe dizziness; Difficulty breathing; Nausea; Vomiting; Diarrhoea; Loss of appetite; Stomach pain; Leg cramps; Swelling of extremities; Headache | Allery; Iron overload syndrome; Haemolytic anaemia; Ulcerative colitis; Stomach ulcers; Thalassemia; Receiving regular blood transfusions; First trimester of pregnancy; Lactation (no data available) |
- Citation: Etemady M, Hajizadeh M, Gidaszewski B, Swain JA, Chua SC, Khajehei M. Use of iron in perinatal anaemia: Indications for women’s health care policies and procedure. World J Obstet Gynecol 2023; 12(4): 33-44
- URL: https://www.wjgnet.com/2218-6220/full/v12/i4/33.htm
- DOI: https://dx.doi.org/10.5317/wjog.v12.i4.33